Novocure Ltd (NVCR) CEO Asaf Danziger Sold $7.5 million of Shares

GuruFocus.com
0

- By insider

CEO of Novocure Ltd (NVCR) Asaf Danziger sold 336,420 shares of NVCR on 01/12/2018 at an average price of $22.33 a share. The total sale was $7.5 million.

NovoCure Ltd is a medical systems developer in the United States. Its primary product is the TTFields delivery system, which is a low-intensity therapy to combat acute tumors. NovoCure Ltd has a market cap of $1.89 billion; its shares were traded at around $21.20 with and P/S ratio of 12.15.


CEO Recent Trades:

  • CEO Asaf Danziger sold 336,420 shares of NVCR stock on 01/12/2018 at the average price of $22.33. The price of the stock has decreased by 5.06% since.

CFO Recent Trades:

  • CFO Wilhelmus Cm Groenhuysen sold 31,132 shares of NVCR stock on 01/09/2018 at the average price of $21.02. The price of the stock has increased by 0.86% since.

  • CFO Wilhelmus Cm Groenhuysen sold 28,868 shares of NVCR stock on 01/04/2018 at the average price of $21.03. The price of the stock has increased by 0.81% since.

Directors and Officers Recent Trades:

  • Chief Science Officer Eilon D. Kirson sold 25,320 shares of NVCR stock on 01/11/2018 at the average price of $22. The price of the stock has decreased by 3.64% since.

For the complete insider trading history of NVCR, click here

.This article first appeared on GuruFocus.


Advertisement

Recommended Stories